Simplex Trading’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57 Buy
69,900
+37,800
+118% +$3.89M ﹤0.01% 8899
2025
Q4
$3.26M Sell
32,100
-73,100
-69% -$5.87M ﹤0.01% 1591
2025
Q3
$5.75M Buy
105,200
+39,100
+59% +$1.95M ﹤0.01% 1338
2025
Q2
$3.51M Sell
66,100
-62,400
-49% -$3.17M ﹤0.01% 1643
2025
Q1
$5.56M Sell
128,500
-17,100
-12% -$866K ﹤0.01% 1243
2024
Q4
$8.18M Sell
145,600
-57,600
-28% -$3.58M ﹤0.01% 1157
2024
Q3
$13.8M Buy
203,200
+100,600
+98% +$5.68M 0.01% 836
2024
Q2
$4.33M Sell
102,600
-143,600
-58% -$7.9M ﹤0.01% 1534
2024
Q1
$17M Buy
246,200
+103,000
+72% +$6.52M 0.01% 799
2023
Q4
$10.6M Buy
143,200
+26,300
+22% +$1.72M 0.01% 1046
2023
Q3
$7.97M Sell
116,900
-31,800
-21% -$2.7M 0.01% 1040
2023
Q2
$14M Buy
148,700
+23,000
+18% +$1.79M 0.01% 722
2023
Q1
$8.52M Sell
125,700
-137,600
-52% -$8.84M 0.01% 985
2022
Q4
$13M Buy
263,300
+87,000
+49% +$3.55M 0.01% 733
2022
Q3
$5.73M Sell
176,300
-4,900
-3% -$202K 0.01% 1106
2022
Q2
$7.14M Buy
181,200
+36,600
+25% +$1.96M 0.01% 945
2022
Q1
$10.1M Sell
144,600
-4,600
-3% -$336K 0.01% 835
2021
Q4
$11.6M Buy
149,200
+40,200
+37% +$3.55M 0.01% 716
2021
Q3
$13.5M Buy
109,000
+100
+0.1% +$10.6K 0.01% 591
2021
Q2
$13.5M Buy
108,900
+108,066
+12,958% +$12.9M 0.01% 585
2021
Q1
$11M Buy
+834
New +$114K 0.02% 435
2020
Q4
Sell
-959
Closed -$9.78M 8536
2020
Q3
$9.78M Buy
959
+238
+33% +$20.6K 0.01% 516
2020
Q2
$6.27M Sell
721
-874
-55% -$69.8K 0.01% 722
2020
Q1
$9.25M Buy
+1,595
New +$129K 0.02% 451
2019
Q4
Sell
-845
Closed -$7.64M 7453
2019
Q3
$7.64M Buy
845
+352
+71% +$40.1K 0.02% 507
2019
Q2
$5.82M Buy
493
+69
+16% +$6.95K 0.02% 607
2019
Q1
$3.67M Sell
424
-1,035
-71% -$88.1K 0.01% 897
2018
Q4
$9.21M Buy
1,459
+308
+27% +$21.1K 0.03% 362
2018
Q3
$9.08M Buy
1,151
+696
+153% +$45.4K 0.03% 399
2018
Q2
$2.72M Sell
455
-86
-16% -$4.63K 0.01% 928
2018
Q1
$146K Sell
541
-25
-4% -$1.22K 0.01% 1487
2017
Q4
$981K Sell
566
-108
-16% -$5.77K 0.04% 408
2017
Q3
$569K Buy
674
+279
+71% +$11.2K 0.02% 602
2017
Q2
$334K Sell
395
-535
-58% -$16.5K 0.01% 883
2017
Q1
$395K Buy
930
+66
+8% +$1.31K 0.02% 809
2016
Q4
$196K Buy
864
+280
+48% +$4.52K 0.01% 1070
2016
Q3
$292K Sell
584
-481
-45% -$8.48K 0.02% 795
2016
Q2
$203K Buy
1,065
+757
+246% +$5.7K 0.01% 979
2016
Q1
$12K Sell
308
-23
-7% -$147 ﹤0.01% 3292
2015
Q4
$24K Sell
331
-447
-57% -$4.16K ﹤0.01% 2534
2015
Q3
$241K Buy
778
+342
+78% +$7.86K 0.02% 802
2015
Q2
$508K Buy
436
+228
+110% +$5.73K 0.04% 390
2015
Q1
$162K Sell
208
-49
-19% -$1.24K 0.02% 819
2014
Q4
$248K Buy
+257
New +$6.25K 0.03% 504

Other funds holding EXAS

Simplex Trading's EXAS Position: Q1 2026 in Review

Simplex Trading sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,521 shares — an estimated $2.32M sold.

Simplex Trading first reported a position in EXAS in Q1 2016 and held it in 24 quarters. The position peaked at $8.14M in Q1 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Simplex Trading reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 22,521 Exact Sciences shares in Q1 2026, an estimated $2.32M.
  • Simplex Trading first reported a position in Exact Sciences in Q1 2016 and held it in 24 quarters.
  • Simplex Trading's Exact Sciences position peaked at $8.14M in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.